Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

NCT05104983 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Tuberous Sclerosis Complex
Epilepsy

Interventions

DRUG: Sirolimus
DRUG: Placebo

Sponsor

Darcy Krueger